Atrial Fibrillation linked to Vascular access Thrombosis in Chronic Hemodialysis Patients

• DOI: 10.5551/jat.6296
• Publication Date: 2011-06-28T11:32:20Z
• Authors: Che-Yi Chou; Jan-Yow Chen; Jiung-Hsiun Liu; Yao-Lung Liu; Hsin-Hung Lin; Ya-Fei Yang; Shu-Ming Wang; Huey-Liang Kuo; Chiu-Ching Huang
• Keywords: Male; Venous Thrombosis; Middle Aged; 3. Good health; 03 medical and health sciences; C-Reactive Protein; 0302 clinical medicine; Renal Dialysis; Risk Factors; Atrial Fibrillation; Humans; Kidney Failure, Chronic; Female; Retrospective Studies

Atrial fibrillation (AF) is characterized by the development of thromboembolic events and is more prevalent among end-stage renal disease patients than in the general population. Vascular access thrombosis (VAT) is a major morbidity in chronic hemodialysis (HD) patients; however, the association between AF and VAT is unknown.We retrospectively reviewed chronic HD patients with functional vascular access between 1997 and 2006. The association between AF and the development of VAT was analyzed using Kaplan-Meier analysis and multivariate Cox proportional hazards regression.A total of 568 chronic HD patients, including 55 (9.7%) patients with AF, were reviewed and 154 (27.1%) patients developed at least one episode of VAT. Patients with AF had worse VAT-free survival than patients without AF (p< 0.001). In Cox regression, age, type of vascular access, atrial fibrillation, diabetes, hypertension, and C-reactive protein were independently linked to the development of VAT ( p= 0.049, < 0.001, < 0.001, 0.001, 0.028 and 0.045). The hazard ratios were 2.1 (95% CI: 1.00-1.03) for arteriovenous graft, 2.47 (95% CI: 1.66-3.69) for AF, 1.72 (95% CI: 1.25-2.39) for diabetes and 1.09 (95% CI: 1.00-1.18) for serum C-reactive protein (every 1 mg/dL increase), respectively.Atrial fibrillaiton is linked to the development of vascular access thrombosis in chronic hemodialysis patients and is independent of traditional VAT risk factors.